Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness And Impact of Nirsevimab In A Nationwide Immunization Program During The 2024 Winter Campaign In Chile (Nirse-CL)

NCT06511687 is registered in ClinicalTrials.gov with Instituto Sistemas Complejos de Ingeniería as lead sponsor.

NCT NCT06511687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06511687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness And Impact of Nirsevimab In A Nationwide Immunization Program During The 2024 Winter Campaign In Chile (Nirse-CL)
Lead sponsor
Instituto Sistemas Complejos de Ingeniería
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2024
Completion date
October 1, 2024
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rsv